You can buy or sell RCUS and other stocks, options, and ETFs commission-free!
Arcus Biosciences, Inc. engages in the development and commercialization of immunotherapies. The firm competes in the segments of the pharmaceutical, biotechnology and other related markets that develop immunotherapies for the treatment of cancer. Read More The company was founded by Terry J. Rosen and Juan Carlos Jaen in 2015 and is headquartered in Hayward, CA. The listed name for RCUS is Arcus Biosciences, Inc.
52 Week High
52 Week Low
— per share
Expected Nov 10, After Hours